Skip to main content

Advertisement

Log in

Response to crizotinib observed in metastatic mediastinum lymph node from a non-small cell lung cancer patient harboring EZRROS1 fusion

  • Letter to the Editor
  • Published:
Journal of Cancer Research and Clinical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

References

Download references

Acknowledgments

Grant from Shanghai Hospital Development Center (Grant No. SHDC12012308). Grant from Health and Family Planning Commission of Shanghai Municipality (Grant No. 2013ZYJB0301). The authors thanked Yuanshan Fu for language proof-reading.

Conflict of interest

We declare that no benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. We also declare that we have no conflict of interest in connection with this paper.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Haiquan Chen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Li, H., Pan, Y., Wang, R. et al. Response to crizotinib observed in metastatic mediastinum lymph node from a non-small cell lung cancer patient harboring EZRROS1 fusion. J Cancer Res Clin Oncol 141, 185–187 (2015). https://doi.org/10.1007/s00432-014-1821-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-014-1821-1

Keywords

Navigation